MENU
VYGR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Voyager Therapeutics (VYGR) Ownership - Who owns Voyager Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
341.41M
P/E Ratio
9.47
Total Cash
345.36M
Projected Growth
N/A
Total Debt
45.35M
Revenue
163.78M
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash/Share
6.32
Total Debt/Equity
N/A
Revenue/Share
2.94 USD as % of share price
Fundamentals
VYGR
Capitalization
341M
P/E Ratio
9.47
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash
345M
Total Cash/Share
6.32
Total Debt
45.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.94%
Revenue
164M
ROE
N/A
Book Value
330M
P/B Ratio
1.03
Cash Flow
N/A
Earnings
0.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
8.45
Current Revenue Per Employee
152030.86
Dividends Per Share - Security
N/A
EBITDA
14.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
7.18
Shares Held By Institutions
363M
Shares Outstanding - Current
54.6M
Total Liabilities
95.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-25.948
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene therapies for fatal and debilitating diseases of the central nervous system
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com